+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Opioids Market by Opioid Types (Natural Opiates, Semi-Synthetic Opioids, Synthetic Opioids), Mode of Administration (Oral Administration, Parenteral Administration, Transdermal Administration), Application, End-User - Global Forecast 2025-2030- Product Image
Opioids Market by Opioid Types (Natural Opiates, Semi-Synthetic Opioids, Synthetic Opioids), Mode of Administration (Oral Administration, Parenteral Administration, Transdermal Administration), Application, End-User - Global Forecast 2025-2030- Product Image
Sale

Opioids Market by Opioid Types (Natural Opiates, Semi-Synthetic Opioids, Synthetic Opioids), Mode of Administration (Oral Administration, Parenteral Administration, Transdermal Administration), Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5977695
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The opioid market is undergoing significant transformation, driven by changing regulatory dynamics, technological advances, and evolving public health priorities. Senior executives in pharmaceuticals, healthcare, and supply chain management require actionable insights to navigate an increasingly complex landscape marked by heightened scrutiny and shifting therapeutic approaches.

Market Snapshot: The Opioids Market

The Opioids Market grew from USD 21.53 billion in 2024 to USD 22.44 billion in 2025. It is expected to continue growing at a CAGR of 4.10%, reaching USD 27.42 billion by 2030. Industry participants—including healthcare providers, pharmaceutical manufacturers, policymakers, and advocacy organizations—are adapting in real time to regulatory advancements and innovations in drug delivery. This evolving environment is characterized by continuous market entry for safer formulations and investments in both opioid and non-opioid therapeutics. Opioid supply chains are under renewed stress amidst changes in global trade policies and heightened regulatory oversight.

Scope & Segmentation

  • Opioid Types: Natural opiates (codeine, morphine), semi-synthetic opioids (hydrocodone, oxycodone), synthetic opioids (fentanyl, methadone).
  • Mode of Administration: Oral (capsules, tablets), parenteral (intramuscular, intravenous), transdermal systems.
  • Application Areas: Anesthesia (general, regional), cough suppression, pain management (acute, chronic).
  • End Users: Clinics, hospitals, home healthcare providers, research institutes.
  • Geographic Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina and select US states), Europe, Middle East & Africa (with market coverage for the United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, and others), Asia-Pacific (including China, India, Japan, Australia, South Korea, Southeast Asian countries).
  • Company Landscape: Analysis includes companies such as AbbVie, Alvogen, Apotex, Daiichi Sankyo, Elite Pharmaceuticals, Endo International, Pfizer, Teva Pharmaceutical Industries, Viatris, and other key sector players.

Key Takeaways for Decision-Makers

  • Technological innovation, including abuse-deterrent formulations and digital monitoring, is reshaping competitive differentiation and compliance priorities across the opioid market.
  • Regulatory updates are requiring rapid adaptation in both product portfolios and supply chain management, as governments focus on risk management and traceability.
  • Stakeholder collaboration with advocacy and regulatory agencies is key to balancing patient access, safety, and responsible opioid stewardship.
  • Regional market variations—influenced by development status, local regulations, and healthcare infrastructure—create unique entry points and partnership opportunities for stakeholders.
  • Investments in non-opioid alternatives, advanced analytics, and integration of digital tools are accelerating as companies seek sustainable and compliant pathways to market leadership.
  • Emerging care models and patient monitoring technologies support broader pain management strategies, further diversifying revenue streams within both institutional and at-home care environments.

Tariff Impact on Opioid Supply Chains

The introduction of United States tariffs in 2025 affected chemical precursors and finished formulations, generating supply chain disruptions and leading manufacturers to reassess sourcing and cost structures. Some companies responded by diversifying suppliers or expanding in-house synthesis, while distributors and exporters renegotiated contracts or explored new end markets. Operational continuity is now reinforced by investments in customs management and import compliance.

Methodology & Data Sources

The analysis incorporates a multi-stage research approach, including secondary data from regulatory filings and clinical databases. Primary data were collected through interviews with clinicians and experts, followed by statistical modeling and workshops that validated preliminary insights. All findings adhere to international data privacy standards.

Why This Report Matters

  • Provides a concise, evidence-based roadmap for optimizing product portfolios, expanding into new markets, and managing compliance risks in the opioid sector.
  • Highlights actionable intelligence essential for investment decisions, strategic planning, and competitive positioning in a high-stakes healthcare environment.

Conclusion

Senior leaders leveraging this report gain clarity on strategies to mitigate risk, foster responsible growth, and align organizational direction with evolving regulatory and market trends in the opioids sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Surge in telemedicine-based medication-assisted treatment for opioid use disorder
5.2. Widespread integration of AI-driven prescription drug monitoring programs to prevent misuse
5.3. Accelerated launch of generic opioid analgesics following landmark patent expirations
5.4. Growing adoption of abuse-deterrent formulations with novel polymer matrix technologies
5.5. Expansion of community pharmacy naloxone distribution through state standing orders
5.6. Rising collaborations between payers and providers on value-based opioid treatment contracts
5.7. Intensified regulatory scrutiny on illicit synthetic opioid analogues like fentanyl and carfentanil
5.8. Shift towards non-opioid pain management alternatives including CGRP and TRPV1 inhibitors
5.9. Enhanced real-world evidence studies demonstrating cost effectiveness of MOUD programs
5.10. Emerging legal challenges around opioid litigation settlements and fund allocation transparency
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Opioids Market, by Opioid Types
8.1. Introduction
8.2. Natural Opiates
8.2.1. Codeine
8.2.2. Morphine
8.3. Semi-Synthetic Opioids
8.3.1. Hydrocodone
8.3.2. Oxycodone
8.4. Synthetic Opioids
8.4.1. Fentanyl
8.4.2. Methadone
9. Opioids Market, by Mode of Administration
9.1. Introduction
9.2. Oral Administration
9.2.1. Capsules
9.2.2. Tablets
9.3. Parenteral Administration
9.3.1. Intramuscular
9.3.2. Intravenous
9.4. Transdermal Administration
10. Opioids Market, by Application
10.1. Introduction
10.2. Anesthesia
10.2.1. General Anesthesia
10.2.2. Regional Anesthesia
10.3. Cough Suppression
10.4. Pain Management
10.4.1. Acute Pain
10.4.2. Chronic Pain
11. Opioids Market, by End-User
11.1. Introduction
11.2. Healthcare Facilities
11.2.1. Clinics
11.2.2. Hospitals
11.3. Home Healthcare
11.4. Research Institutes
12. Americas Opioids Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Opioids Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Opioids Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. AbbVie Inc.
15.3.2. Alvogen
15.3.3. Apotex Inc.
15.3.4. Biesterfeld SE
15.3.5. Daiichi Sankyo Company, Limited
15.3.6. Elite Pharmaceuticals, Inc.
15.3.7. Endo International plc
15.3.8. Fresenius SE & Co. KGaA
15.3.9. Hikma Pharmaceuticals PLC
15.3.10. Humanwell Healthcare (Group) Co., Ltd.
15.3.11. Indivior PLC
15.3.12. Johnson & Johnson Services, Inc.
15.3.13. Johnson Matthey Group
15.3.14. Kyowa Hakko Kirin Co. Ltd.
15.3.15. Mallinckrodt plc
15.3.16. Nutriband Inc.
15.3.17. Pfizer Inc.
15.3.18. Piramal Pharma Limited
15.3.19. Purdue Pharma L.P.
15.3.20. QuVa Pharma, Inc
15.3.21. SCA Pharma
15.3.22. Spectrum Chemical Mfg. Corp.
15.3.23. Teva Pharmaceutical Industries Ltd.
15.3.24. Tofigh Daru Research & Engineering Company
15.3.25. Verve HumanCare Laboratories
15.3.26. Viatris Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. OPIOIDS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL OPIOIDS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL OPIOIDS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2024 VS 2030 (%)
FIGURE 6. GLOBAL OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL OPIOIDS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL OPIOIDS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL OPIOIDS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL OPIOIDS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES OPIOIDS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES OPIOIDS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. OPIOIDS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. OPIOIDS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. OPIOIDS MARKET: RESEARCHAI
FIGURE 24. OPIOIDS MARKET: RESEARCHSTATISTICS
FIGURE 25. OPIOIDS MARKET: RESEARCHCONTACTS
FIGURE 26. OPIOIDS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. OPIOIDS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL OPIOIDS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL OPIOIDS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL OPIOIDS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL OPIOIDS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL OPIOIDS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL OPIOIDS MARKET SIZE, BY NATURAL OPIATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL OPIOIDS MARKET SIZE, BY NATURAL OPIATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL OPIOIDS MARKET SIZE, BY CODEINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL OPIOIDS MARKET SIZE, BY CODEINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL OPIOIDS MARKET SIZE, BY MORPHINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL OPIOIDS MARKET SIZE, BY MORPHINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL OPIOIDS MARKET SIZE, BY HYDROCODONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL OPIOIDS MARKET SIZE, BY HYDROCODONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL OPIOIDS MARKET SIZE, BY OXYCODONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL OPIOIDS MARKET SIZE, BY OXYCODONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL OPIOIDS MARKET SIZE, BY FENTANYL, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL OPIOIDS MARKET SIZE, BY FENTANYL, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL OPIOIDS MARKET SIZE, BY METHADONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL OPIOIDS MARKET SIZE, BY METHADONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL OPIOIDS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL OPIOIDS MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL OPIOIDS MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL OPIOIDS MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL OPIOIDS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL OPIOIDS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL OPIOIDS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL OPIOIDS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL OPIOIDS MARKET SIZE, BY TRANSDERMAL ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL OPIOIDS MARKET SIZE, BY TRANSDERMAL ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL OPIOIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL OPIOIDS MARKET SIZE, BY ANESTHESIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL OPIOIDS MARKET SIZE, BY ANESTHESIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL OPIOIDS MARKET SIZE, BY GENERAL ANESTHESIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL OPIOIDS MARKET SIZE, BY GENERAL ANESTHESIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL OPIOIDS MARKET SIZE, BY REGIONAL ANESTHESIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL OPIOIDS MARKET SIZE, BY REGIONAL ANESTHESIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL OPIOIDS MARKET SIZE, BY ANESTHESIA, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL OPIOIDS MARKET SIZE, BY COUGH SUPPRESSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL OPIOIDS MARKET SIZE, BY COUGH SUPPRESSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL OPIOIDS MARKET SIZE, BY ACUTE PAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL OPIOIDS MARKET SIZE, BY ACUTE PAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL OPIOIDS MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL OPIOIDS MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL OPIOIDS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL OPIOIDS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL OPIOIDS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL OPIOIDS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL OPIOIDS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL OPIOIDS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL OPIOIDS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL OPIOIDS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL OPIOIDS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL OPIOIDS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS OPIOIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS OPIOIDS MARKET SIZE, BY ANESTHESIA, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS OPIOIDS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS OPIOIDS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS OPIOIDS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES OPIOIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES OPIOIDS MARKET SIZE, BY ANESTHESIA, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES OPIOIDS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES OPIOIDS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES OPIOIDS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES OPIOIDS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 141. CANADA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2024 (USD MILLION)
TABLE 142. CANADA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2025-2030 (USD MILLION)
TABLE 143. CANADA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2024 (USD MILLION)
TABLE 144. CANADA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2025-2030 (USD MILLION)
TABLE 145. CANADA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 146. CANADA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 147. CANADA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 148. CANADA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 149. CANADA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 150. CANADA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 151. CANADA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 152. CANADA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 153. CANADA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 154. CANADA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 155. CANADA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. CANADA OPIOIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. CANADA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2024 (USD MILLION)
TABLE 158. CANADA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2025-2030 (USD MILLION)
TABLE 159. CANADA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 160. CANADA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 161. CANADA OPIOIDS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 162. CANADA OPIOIDS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 163. CANADA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 164. CANADA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 165. MEXICO OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2024 (USD MILLION)
TABLE 166. MEXICO OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2025-2030 (USD MILLION)
TABLE 167. MEXICO OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2024 (USD MILLION)
TABLE 168. MEXICO OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2025-2030 (USD MILLION)
TABLE 169. MEXICO OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 170. MEXICO OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 171. MEXICO OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 172. MEXICO OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 173. MEXICO OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 174. MEXICO OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 175. MEXICO OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 176. MEXICO OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 177. MEXICO OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 178. MEXICO OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 179. MEXICO OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. MEXICO OPIOIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. MEXICO OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2024 (USD MILLION)
TABLE 182. MEXICO OPIOIDS MARKET SIZE, BY ANESTHESIA, 2025-2030 (USD MILLION)
TABLE 183. MEXICO OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 184. MEXICO OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 185. MEXICO OPIOIDS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 186. MEXICO OPIOIDS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 187. MEXICO OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 188. MEXICO OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL OPIOIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL OPIOIDS MARKET SIZE, BY ANESTHESIA, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL OPIOIDS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL OPIOIDS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA OPIOIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA OPIOIDS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA OPIOIDS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM OPIOIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM OPIOIDS MARKET SIZE, BY ANESTHESIA, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM OPIOIDS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM OPIOIDS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 287. GERMANY OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2024 (USD MILLION)
TABLE 288. GERMANY OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2025-2030 (USD MILLION)
TABLE 289. GERMANY OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2024 (USD MILLION)
TABLE 290. GERMANY OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2025-2030 (USD MILLION)
TABLE 291. GERMANY OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 292. GERMANY OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 293. GERMANY OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 294. GERMANY OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 295. GERMANY OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 296. GERMANY OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 297. GERMANY OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 298. GERMANY OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 299. GERMANY OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 300. GERMANY OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 301. GERMANY OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. GERMANY OPIOIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. GERMANY OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2024 (USD MILLION)
TABLE 304. GERMANY OPIOIDS MARKET SIZE, BY ANESTHESIA, 2025-2030 (USD MILLION)
TABLE 305. GERMANY OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 306. GERMANY OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 307. GERMANY OPIOIDS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 308. GERMANY OPIOIDS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 309. GERMANY OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 310. GERMANY OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 311. FRANCE OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2024 (USD MILLION)
TABLE 312. FRANCE OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2025-2030 (USD MILLION)
TABLE 313. FRANCE OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2024 (USD MILLION)
TABLE 314. FRANCE OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2025-2030 (USD MILLION)
TABLE 315. FRANCE OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 316. FRANCE OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 317. FRANCE OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 318. FRANCE OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 319. FRANCE OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 320. FRANCE OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 321. FRANCE OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 322. FRANCE OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 323. FRANCE OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 324. FRANCE OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 325. FRANCE OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 326. FRANCE OPIOIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 327. FRANCE OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2024 (USD MILLION)
TABLE 328. FRANCE OPIOIDS MARKET SIZE, BY ANESTHESIA, 2025-2030 (USD MILLION)
TABLE 329. FRANCE OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 330. FRANCE OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 331. FRANCE OPIOIDS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 332. FRANCE OPIOIDS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 333. FRANCE OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 334. FRANCE OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 335. RUSSIA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2024 (USD MILLION)
TABLE 336. RUSSIA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2025-2030 (USD MILLION)
TABLE 337. RUSSIA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2024 (USD MILLION)
TABLE 338. RUSSIA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2025-2030 (USD MILLION)
TABLE 339. RUSSIA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 340. RUSSIA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 341. RUSSIA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 342. RUSSIA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 343. RUSSIA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 344. RUSSIA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 345. RUSSIA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 346. RUSSIA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 347. RUSSIA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 348. RUSSIA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 349. RUSSIA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 350. RUSSIA OPIOIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 351. RUSSIA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2024 (USD MILLION)
TABLE 352. RUSSIA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2025-2030 (USD MILLION)
TABLE 353. RUSSIA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 354. RUSSIA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 355. RUSSIA OPIOIDS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 356. RUSSIA OPIOIDS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 357. RUSSIA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 358. RUSSIA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 359. ITALY OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2024 (USD MILLION)
TABLE 360. ITALY OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2025-2030 (USD MILLION)
TABLE 361. ITALY OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2024 (USD MILLION)
TABLE 362. ITALY OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2025-2030 (USD MILLION)
TABLE 363. ITALY OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 364. ITALY OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 365. ITALY OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2024 (USD MILLION)
TABLE 366. ITALY OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2025-2030 (USD MILLION)
TABLE 367. ITALY OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 368. ITALY OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 369. ITALY OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 370. ITALY OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 371. ITALY OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 372. ITALY OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 373. ITALY OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 374. I

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Opioids market report include:
  • AbbVie Inc.
  • Alvogen
  • Apotex Inc.
  • Biesterfeld SE
  • Daiichi Sankyo Company, Limited
  • Elite Pharmaceuticals, Inc.
  • Endo International plc
  • Fresenius SE & Co. KGaA
  • Hikma Pharmaceuticals PLC
  • Humanwell Healthcare (Group) Co., Ltd.
  • Indivior PLC
  • Johnson & Johnson Services, Inc.
  • Johnson Matthey Group
  • Kyowa Hakko Kirin Co. Ltd.
  • Mallinckrodt plc
  • Nutriband Inc.
  • Pfizer Inc.
  • Piramal Pharma Limited
  • Purdue Pharma L.P.
  • QuVa Pharma, Inc
  • SCA Pharma
  • Spectrum Chemical Mfg. Corp.
  • Teva Pharmaceutical Industries Ltd.
  • Tofigh Daru Research & Engineering Company
  • Verve HumanCare Laboratories
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 22.44 Billion
Forecasted Market Value ( USD ) by 2030 $ 27.42 Billion
Compound Annual Growth Rate4.1%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Non-Opioid Therapeutics Market by Drug Type (Acetaminophen, Antidepressants, Antiepileptics), Route of Administration (Intravenous, Oral, Rectal), Application, End Use, Distribution Channel - Global Forecast 2025-2030 - Product Image

Non-Opioid Therapeutics Market by Drug Type (Acetaminophen, Antidepressants, Antiepileptics), Route of Administration (Intravenous, Oral, Rectal), Application, End Use, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Opioid Narcotics Market by Route of Administration (Injectable, Nasal, Oral), Product Type (Branded, Generic), Molecule Type, Formulation Type, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Opioid Narcotics Market by Route of Administration (Injectable, Nasal, Oral), Product Type (Branded, Generic), Molecule Type, Formulation Type, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Non-opioid Pain Patches Market Size, Share & Trends Analysis Report By Patch Type (Lidocaine, Diclofenac, Methyl Salicylate, Capsaicin, Ketoprofen), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Non-opioid Pain Patches Market Size, Share & Trends Analysis Report By Patch Type (Lidocaine, Diclofenac, Methyl Salicylate, Capsaicin, Ketoprofen), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Opioid Use Disorder Market Size, Share & Trends Analysis Report By Drug, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Opioid Use Disorder Market Size, Share & Trends Analysis Report By Drug, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Opioid Dependence- Pipeline Insight, 2025 - Product Image

Opioid Dependence- Pipeline Insight, 2025

  • Clinical Trials
  • 80 Pages
  • Global
From

About the Opioids Market

Analgesics are a class of drugs used to relieve pain. Opioids are a type of analgesic that act on the nervous system to reduce the intensity of pain signals sent to the brain. Opioids are typically prescribed for moderate to severe pain, and are often used to treat chronic pain. They can be taken orally, injected, or applied topically. Opioids can be highly addictive and have a high potential for abuse, so they are typically prescribed with caution. Opioids are a major component of the analgesic market, and are used to treat a variety of conditions. Commonly prescribed opioids include oxycodone, hydrocodone, morphine, and codeine. Other analgesics, such as non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen, are also used to treat pain. Companies in the opioids market include Purdue Pharma, Endo Pharmaceuticals, Teva Pharmaceuticals, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.